BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23093487)

  • 1. Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
    Weisbrod AB; Nilubol N; Weinstein LS; Simonds WF; Libutti SK; Jensen RT; Marx SJ; Kebebew E
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E109-14. PubMed ID: 23093487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
    Weisbrod AB; Liewehr DJ; Steinberg SM; Patterson EE; Libutti SK; Linehan WM; Nilubol N; Kebebew E
    Ann Surg Oncol; 2012 Jun; 19(6):2054-9. PubMed ID: 22350603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors.
    Gudmundsdottir H; Graham RP; Sonbol MB; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Habermann EB; Halfdanarson TR; Cleary SP
    J Surg Oncol; 2021 Dec; 124(7):1077-1084. PubMed ID: 34310723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hereditary forms of pancreatic neuroendocrine tumors.
    DeLellis RA
    Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours.
    Donegan D; Singh Ospina N; Rodriguez-Gutierrez R; Al-Hilli Z; Thompson GB; Clarke BL; Young WF
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):199-206. PubMed ID: 27770475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.
    Lewis MA; Thompson GB; Young WF
    World J Surg; 2012 Jun; 36(6):1375-81. PubMed ID: 22382771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
    Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
    Dʼsouza SL; Elmunzer BJ; Scheiman JM
    J Clin Gastroenterol; 2014; 48(5):458-61. PubMed ID: 24356459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 4.
    Gupta S; Whaley RD; Erickson LA
    Mayo Clin Proc; 2024 Jan; 99(1):177-178. PubMed ID: 38176828
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
    Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
    Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
    Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
    Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
    Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
    Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
    Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
    JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.
    Selberherr A; Koperek O; Riss P; Scheuba C; Niederle MB; Kaderli R; Perren A; Niederle B
    Orphanet J Rare Dis; 2019 Feb; 14(1):54. PubMed ID: 30795813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
    Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
    Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.